Biggest public health threats today:
The inability to prevent and control chronic diseases, Lucinda Maine of the American Association of Colleges of Pharmacy.
The interconnectedness of diseases, says Anne Schuchat of the CDC.
The need for more research explaining how social context impacts genes resulting in chronic diseases, says Reed Tuckson of Tuckson Health Connections.
The need to increase the safety of healthcare delivery in hospitals and other healthcare settings, says Richard Kronick of the Agency for Healthcare Research and Quality.
Healthcare communities, with inpatient and outpatient services like nursing homes and ambulatory facilities, need to do more to work together to reduce overuse of antibiotics, says Schuchat .
AHRQ is spending $6 million in 2015 to reduce the spread of antibiotic resistant bugs and is making progress but the spread remains a "challenge" says Kronick.
Regarding shifting public opinion on vaccinations, 2015 was an "extraordinary" year in that parents with children who couldn't get vaccines, like those with leukemia or were under 1 year, spoke out about them as "innocent bystanders" and polls are showing that opinion is shifting, says Schuchat.
No chapter of ALS association takes credit for ice bucket challenge, it was the work of 3 young men who took what they knew about sports strategy and turned it into a public platform for educating the public about ALS, says ALS Assn CEO Barbara Newhouse.
The second panel just ended; the final panel will start soon.
The last panel will focus on regulatory science.
• Marc Boutin, J.D., chief executive officer, National Health Council
• William Hait, M.D., Ph.D., global head, Janssen Research & Development
• Stephen M. Ostroff, M.D., acting commissioner, Food and Drug Administration
• Amy Comstock Rick, J.D., president & CEO, Food and Drug Law Institute
• Larry Shapiro, Executive Vice Chancellor for Medical Affairs, Washington University in St. Louis
Americans are living longer, but they are living longer, sicker and policy makers and the media aren't talking about it and they need to, says Tuckson.
FDA'scritical priority is to keep up with the pace of technological change, says Stephen Ostroff acting FDA commissioner.
He says the rate of drug approval has increased because there is so much more pre discussion between regulators and companies before application is filed with the agency.
FDA is continuing to work on finding the right quantitative model to balance risk versus benefit in permitting high risk treatments to patients, Ostroff says.
fDA is comfortable with 21st century cures bill that is pending in Congress and that they'll continue to be able to evaluate the safety and effectiveness of new medical devices but remains concerned it won't have all the funds that it needs to fulfill all the things that will be required of the agency under the legislation, Ostroff says. He says the agency will keep pushing congress for more funding.
The FDA is hiring. It needs more people with experience in analytics, informatics and analyst it's that can integrate data from different scientific disciplines , says Ostroff.